Does IRBESARTAN Cause Maternal exposure timing unspecified? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Maternal exposure timing unspecified have been filed in association with IRBESARTAN (Irbesartan). This represents 0.2% of all adverse event reports for IRBESARTAN.
17
Reports of Maternal exposure timing unspecified with IRBESARTAN
0.2%
of all IRBESARTAN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From IRBESARTAN?
Of the 17 reports, 1 (5.9%) required hospitalization.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which IRBESARTAN Alternatives Have Lower Maternal exposure timing unspecified Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE